Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegenerative Ocular Diseases THN391, a mAb designed to block neuroinflammation triggered by fibrin, demonstrated effectiveness in protecting against vascular and neuronal degeneration

Fibrin Sealants Global Market to Reach $2.6 Billion by 2031: Surge in the Prevalence of Chronic Diseases Fuels the Sector Dublin, March 27, 2023 (GLOBE NEWSWIRE) -- The "Fibrin Sealants Market By Dosage Forms, By Application, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been...

Global Bleeding Disorders Treatment Market Report 2022: Increased Focus of Pharmaceutical Companies on Recombinant Products Creates Opportunities Dublin, Sept. 09, 2022 (GLOBE NEWSWIRE) -- The "Global Bleeding Disorders Treatment Market By Drug Type, By Disease Type, By Distribution Channel, By End User By Region, Competition, Forecast &...